<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://wiki.dspt.info/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=WillaimsMarsden840</id>
		<title>DSP Wiki - User contributions [en]</title>
		<link rel="self" type="application/atom+xml" href="http://wiki.dspt.info/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=WillaimsMarsden840"/>
		<link rel="alternate" type="text/html" href="http://wiki.dspt.info/index.php/Special:Contributions/WillaimsMarsden840"/>
		<updated>2026-05-15T05:21:02Z</updated>
		<subtitle>User contributions</subtitle>
		<generator>MediaWiki 1.24.2</generator>

	<entry>
		<id>http://wiki.dspt.info/index.php?title=User:WillaimsMarsden840&amp;diff=19707</id>
		<title>User:WillaimsMarsden840</title>
		<link rel="alternate" type="text/html" href="http://wiki.dspt.info/index.php?title=User:WillaimsMarsden840&amp;diff=19707"/>
				<updated>2013-05-20T02:32:35Z</updated>
		
		<summary type="html">&lt;p&gt;WillaimsMarsden840: Created page with &amp;quot;sex poker casino viagra cialis pharmacy http://redtube.com http://www.sextube.com http://www.xtube.com  A protein that could be harnessed to prevent or reverse the onset of ty...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;sex poker casino viagra cialis pharmacy&lt;br /&gt;
http://redtube.com&lt;br /&gt;
http://www.sextube.com&lt;br /&gt;
http://www.xtube.com&lt;br /&gt;
&lt;br /&gt;
A protein that could be harnessed to prevent or reverse the onset of type 1 diabetes has been identified by Australian researchers.&lt;br /&gt;
&lt;br /&gt;
The researchers found the protein - CD52 - plays a key role in protecting the body against excessive immune responses, and could be used to treat other autoimmune disorders such as multiple sclerosis and rheumatoid arthritis.&lt;br /&gt;
&lt;br /&gt;
Study leader, Professor Len Harrison, of the Walter and Eliza Hall Institute, says the team has already found CD52 prevents type 1 diabetes in mouse models and is confident of moving &amp;quot;quickly to clinical trials&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
The findings, published today in Nature Immunology, focuses on the role CD52 plays in suppressing the body's immune response to the specific antigens that drive autoimmune disease.&lt;br /&gt;
&lt;br /&gt;
Autoimmune diseases, such as type 1 diabetes, develop when the immune system begins to attack the body's own tissues.&lt;br /&gt;
&lt;br /&gt;
The protein CD52 appears to play a dominant role in controlling or suppressing immune activity in the early stages of the immune response, Harrison says.&lt;br /&gt;
&lt;br /&gt;
Harrison and colleagues' findings follow on from their earlier discovery T cells, specialised immune cells, that regulate the activity of other T cells.&lt;br /&gt;
&lt;br /&gt;
Harrison says this latest paper outlines the mechanism by which these regulatory T cells work.&lt;br /&gt;
&lt;br /&gt;
Works like a brake&lt;br /&gt;
The researchers found T cells that carry high levels of CD52 release the CD52 to &amp;quot;dampen down or put a brake on&amp;quot; the growth of T cells being activated by the disease-causing antigens.&lt;br /&gt;
&lt;br /&gt;
Harrison says their work shows people with type 1 diabetes are less able to generate CD52 cells and therefore lose this protection.&lt;br /&gt;
&lt;br /&gt;
They were able to demonstrate the link with the onset of the autoimmune disease as the removal of the CD52-producing immune cells in mouse models led to the rapid development of diabetes.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;The data we have so far indicates CD52 is an effective immune-suppressing agent so we are excited about its therapeutic potential,&amp;quot; says Harrison.&lt;br /&gt;
&lt;br /&gt;
The discovery of the protective mechanism could also provide a tool to identify people at risk of developing autoimmune diseases.&lt;br /&gt;
&lt;br /&gt;
Harrison says he and colleagues have been able to measure a deficiency of this mechanism in laboratory tests and hope to ultimately screen for CD52 deficiency to pinpoint people at risk of specific autoimmune diseases.&lt;br /&gt;
&lt;br /&gt;
He says boosting the levels of CD52 in people at risk may be one approach to developing a treatment for diabetes.&lt;br /&gt;
valium phentermine xanax&lt;/div&gt;</summary>
		<author><name>WillaimsMarsden840</name></author>	</entry>

	</feed>